LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Lessons for a SECURE Future: Evaluating Diversity in Crop Biotechnology Across Regulatory Regimes.

George, Dalton R / Hornstein, Eli D / Clower, Carrie A / Coomber, Allison L / Dillard, DeShae / Mugwanya, Nassib / Pezzini, Daniela T / Rozowski, Casey

Frontiers in bioengineering and biotechnology

2022  Volume 10, Page(s) 886765

Abstract: Regulation of next-generation crops in the United States under the newly implemented "SECURE" rule promises to diversify innovation in agricultural biotechnology. Specifically, SECURE promises to expand the number of products eligible for regulatory ... ...

Abstract Regulation of next-generation crops in the United States under the newly implemented "SECURE" rule promises to diversify innovation in agricultural biotechnology. Specifically, SECURE promises to expand the number of products eligible for regulatory exemption, which proponents theorize will increase the variety of traits, genes, organisms, and developers involved in developing crop biotechnology. However, few data-driven studies have looked back at the history of crop biotechnology to understand how specific regulatory pathways have affected diversity in crop biotechnology and how those patterns might change over time. In this article, we draw upon 30 years of regulatory submission data to 1) understand historical diversification trends across the landscape and history of past crop biotechnology regulatory pathways and 2) forecast how the new SECURE regulations might affect future diversification trends. Our goal is to apply an empirical approach to exploring the relationship between regulation and diversity in crop biotechnology and provide a basis for future data-driven analysis of regulatory outcomes. Based on our analysis, we suggest that diversity in crop biotechnology does not follow a single trajectory dictated by the shifts in regulation, and outcomes of SECURE might be more varied and restrictive despite the revamped exemption categories. In addition, the concept of confidential business information and its relationship to past and future biotechnology regulation is reviewed in light of our analysis.
Language English
Publishing date 2022-05-02
Publishing country Switzerland
Document type Journal Article
ZDB-ID 2719493-0
ISSN 2296-4185
ISSN 2296-4185
DOI 10.3389/fbioe.2022.886765
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top